Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00229ApprovedSmall molecule
Cefotiam is a cephalosporin antibiotic used to treat a variety of bacterial infections. One of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
- Mechanism
- Curator reviewed
The bactericidal activity of cefotiam results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
- Primary indication
- For treatment of severe infections caused by susceptible bacteria.Curator reviewed · 1 structured indication
- Formula / weight
- C18H23N9O4S3 · 525.628 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
QYQDKDWGWDOFFU-IUODEOHRSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3CCN(C)C)=C(N1C(=O)[C@H]2NC(=O)CC1=CSC(N)=N1)C(O)=OTargets
Transporters
What you can answer from here — as of September 23, 2026
3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Cefotiam, and which of those have an active Phase 3 trial?